Copyright
©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Rheumatol. Nov 12, 2015; 5(3): 127-130
Published online Nov 12, 2015. doi: 10.5499/wjr.v5.i3.127
Published online Nov 12, 2015. doi: 10.5499/wjr.v5.i3.127
Epigenetic targets of rheumatoid arthritis
Ghazi Chabchoub, Laboratoire de Génétique Moléculaire Humaine, Faculté de Médecine de Sfax, 3000 Sfax, Tunisia
Ghazi Chabchoub, Caisse National d’assurance Maladie, 3021 Sakiet Ezzit, Tunisia
Author contributions: Chabchoub G solely contributed to this paper.
Conflict-of-interest statement: No conflict of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Ghazi Chabchoub, MD, PhD, Médecin Inspecteur, Caisse National d’assurance Maladie, Rue Mongi Slim Sakiet Ezzit, 3021 Sakiet Ezzit, Tunisia. ghazi.chabchoub@laposte.net
Telephone: +216-98-291120
Received: February 5, 2015
Peer-review started: February 7, 2015
First decision: April 10, 2015
Revised: August 24, 2015
Accepted: September 7, 2015
Article in press: September 8, 2015
Published online: November 12, 2015
Processing time: 281 Days and 13.3 Hours
Peer-review started: February 7, 2015
First decision: April 10, 2015
Revised: August 24, 2015
Accepted: September 7, 2015
Article in press: September 8, 2015
Published online: November 12, 2015
Processing time: 281 Days and 13.3 Hours
Core Tip
Core tip: This paper has highlighted the numerous processes involved in the pathogenesis of rheumatoid arthritis (RA) that are modulated by epigenetic mechanisms. This is important hypotheses to explore a novel therapeutic target in RA.